Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Blood|November 20, 2015
Primary acute myeloid leukemia cells with overexpression of EVI-1 are sensitive to all-trans retinoic acidHan J M P Verhagen, Marjon A Smit, Arjo Rutten, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
MicroRNA profiling can classify acute leukemias of ambiguous lineage as either acute myeloid leukemia or acute lymphoid leukemiaDavid C de Leeuw, Willemijn van den Ancker, Fedor Denkers, et al.
Plos One|November 19, 2013
Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cellsGerrit J Schuurhuis, Michael H Meel, Floris Wouters, et al.
Blood Neoplasia|June 24, 2025
Pharmacological targeting of CBX7 alters the epigenetic landscape and induces differentiation of leukemic cellsAnne P de Groot, Chelsea R Wilson, Ellen Weersing, et al.
Leukemia|February 15, 2023
Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progressionMargot F van Spronsen, Diana Hanekamp, Theresia M Westers, et al.
Cancer Research|September 7, 2018
VEGFC Antibody Therapy Drives Differentiation of AMLKim R Kampen, Frank J G Scherpen, Hasan Mahmud, et al.
Blood Advances|December 22, 2020
IGFBP7 activates retinoid acid-induced responses in acute myeloid leukemia stem and progenitor cellsNoortje van Gils, Han J M P Verhagen, Arjo Rutten, et al.
British Journal of Haematology|March 25, 2021
Distinct bone marrow immunophenotypic features define the splicing factor 3B subunit 1 (SF3B1)-mutant myelodysplastic syndromes subtypeCarolien Duetz, Theresia M Westers, Florentien E M In 't Hout, et al.
Iscience|September 13, 2022
Targeting histone methylation to reprogram the transcriptional state that drives survival of drug-tolerant myeloid leukemia persistersNoortje van Gils, Han J M P Verhagen, Michaël Broux, et al.
Cytometry. Part B, Clinical Cytometry|August 23, 2024
The role of the primitive marker CD133 in CD34-negative acute myeloid leukemia for the detection of leukemia stem cellsTom Reuvekamp, Luca L G Janssen, Lok Lam Ngai, et al.
Pageof 3